Loving a Stranger In High Grade

Abrams, Sandra Lea
June 2004
Investment Dealers' Digest;6/28/2004, Vol. 70 Issue 26, p46
Trade Publication
Focuses on the short-term financing of Boston Scientific Corp., a medical device maker, in the U.S. Importance of internal cash flow to fund the research and development and acquisition needs of the company; Impact of acquisitions on the firm's growth; Services of the firm.


Related Articles

  • Boston Sci buying Asthmatx for initial payment of $193.5M. PEDERSEN, AMANDA // Medical Device Daily;9/21/2010, Vol. 14 Issue 183, p1 

    The article reports on the plan of medical device company Boston Scientific of Natick, Massachusetts, to purchase Asthmatx of Sunnyvale, California. Boston Scientific will pay upfront of 193 million dollars and additional 250 million dollars. The addition payment will depend on achievement of...

  • Boston Sci completes $193M acquisition of Sadra Medical.  // Medical Device Daily;1/6/2011, Vol. 15 Issue 4, p1 

    The article reports on the completion of the 193-million U.S. dollar acquisition of Sadra Medical by Boston Scientific, which was first announced on November 22, 2010. The acquisition involves the adjustment of shares by one or two percent of the company in 2011, 2012 and 2013. According to Ray...

  • Boston Scientific Offers $25 Billion to Nab Guidant From J&J.  // Medical Design Technology;Jan2006, Vol. 10 Issue 1, p8 

    The article reports that a 25 billion-dollar offer was made by Boston Scientific Corp. on Guidant Corp. in replacement of its agreement to Johnson & Johnson in the U.S. The decision of Boston was made after it was convinced that Johnson was undervaluing Guidant. According to Boston, the...

  • The Price of Growth in the Medical-Device Industry. Garber, Alan M. // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p337 

    The article presents the authors views on recent changes in the medical-device industry. Details related to the merger between Boston Scientific Corp. with Guidant Corp. Also discussed is the controversy surrounding defective Guidant products. The author compares the growth of the device...

  • Abbott closes $215M Ibis buy; Boston Sci acquires Labcoat.  // Medical Device Daily;1/7/2009, Vol. 13 Issue 3, p3 

    This section offers news briefs on mergers and acquisitions in the U.S. medical device industry as of January 7, 2009. Abbott Laboratories has completed its acquisition of Ibis Biosciences, an Isis Pharmaceuticals subsidiary, for $175 million. Labcoat, a privately-held, development-stage...

  • Despite difficulties, med-tech industry still having success. HAIMOVITCH, LARRY // Medical Device Daily;1/4/2011, Vol. 15 Issue 2, p1 

    This article looks back at the performance of the medical device industry in the U.S. in 2010. It highlights the lackluster revenue growth for some companies, including Medtronic, Boston Scientific and Saint Jude Medical. It also recalls the acquisition of companies and their technologies by big...

  • Healthcare Still Fertile Ground for Buyers. Cody, Tamika // Mergers & Acquisitions Report;2/28/2011, Vol. 24 Issue 9, p7 

    The article examines the sustained interest for acquisitions in the healthcare industry. Analysts who attended Morningstar's Second Annual Healthcare Conference forecast sustained acquisition activity in the sector, particularly in healthcare services and deals aimed at capturing emerging...

  • With 18% Revenue Drop, Guidant Unit Drags Down Boston Scientific Growth.  // Medical Design Technology;Aug2006, Vol. 10 Issue 8, p8 

    The article reports on the decline in the revenue of Boston Scientific Corp. which is related to its acquisition of Guidant Corp. Boston Scientific chief financial officer, Larry Best, justifies the 18% revenue drop and states that they expect growth and stabilization from the acquisition within...

  • Acquisitions.  // Cardiovascular Device Update;Aug2007, Vol. 13 Issue 8, p19 

    This section offers news brief related to acquisition activities in the cardiovascular device industry. All-cash acquisition of the surgical cryoablation business of CryoCath Technologies by ATS Medical has been completed. Boston Scientific is planning to sell is fluid management business....


Read the Article


Sign out of this library

Other Topics